David Greenstein is categorized under Internal Medicine Doctors in Newburyport, MA and active since 2010.
David Greenstein was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David Greenstein at the company’s single location by writing to 1 Wallace Bashaw Way, Newburyport, Massachusetts MA 01950 or by phoning (978) 462-0574. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | David Greenstein |
| Contact Person: | David Greenstein |
| Address: | 1 Wallace Bashaw Way, Newburyport, Massachusetts 01950 |
| Phone Number: | (978) 462-0574 |
| Website Address: | nedermatology.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
David Greenstein was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Greenstein for inquiries that concern David Greenstein by calling the company number (978) 462-0574, as your correspondence is most welcome. Additionally, the physical location of the single location of David Greenstein can be found at the coordinates 42.811834,-70.893957 as well as the street address 1 Wallace Bashaw Way in Newburyport, Massachusetts 01950.
For its online presence, you may visit David Greenstein’s website at nedermatology.com and engage with its social media outlets through on Twitter and on Facebook.